Copper promotes the formation of blood vessels, including those that supply tumors. Depleting copper can deprive the tumor of its suppliers.
Safety and precautions
Chelating drugs carry a risk of side effects and should be taken only as directed by a qualified healthcare professional who will monitor your use.
Side effects
Blood-related
- Low red blood cell count (anemia)
- Low neutrophil count (neutropenia), sometimes accompanied by fever
- Low white blood cell count (leukopenia)
- Low blood platelet count (thrombocytopenia)
Gastrointestinal
- Sulfur burps
- Nausea
- Vomiting
- Diarrhea
- Constipation
- Abdominal pain
Neurologic
- Dizziness
- Neuropathy
Other
- Fatigue
Interactions with cancer treatment
A small trial found that combining TM with irinotecan, 5-fluorouracil, and leucovorin (IFL) treatment did not increase toxicity or interfere with treatment.1Gartner EM, Griffith KA et al. A pilot trial of the anti-angiogenic copper lowering agent tetrathiomolybdate in combination with irinotecan, 5-flurouracil, and leucovorin for metastatic colorectal cancer. Investigational New Drugs. 2009 Apr;27(2):159-65.
References